Testing in Crisis
Clinical labs struggle to match tests and testing strategies to the challenges of the covid-19 pandemic.
Read MorePosted by Laurie Bonner | Jul 1, 2020 | Covid 19, Uncategorized |
Clinical labs struggle to match tests and testing strategies to the challenges of the covid-19 pandemic.
Read MorePosted by Laurie Bonner | May 18, 2020 | Uncategorized |
The EKF desktop analyzer will complement Tosoh’s line of high-performance liquid chromatography equipment for HbA1c analysis in core laboratories.
Read MorePosted by Laurie Bonner | May 11, 2020 | Blood Gas Analyzers |
Agency clearance will allow healthcare personnel to perform bedside critical care testing, with lab-quality results in as little as 1 minute.
Read MorePosted by | Apr 15, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
CQuentia’s covid-19 assay has received FDA emergency use authorization, and its lab has the capacity to process more than 20,000 samples per month.
Read MorePosted by Steve Halasey | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Abbott’s new test is the fastest available molecular point-of-care test for the diagnosis of covid-19, delivering positive results in as little as 5 minutes and negative results in 13 minutes.
Read More